Evidence map›Paper›PMID 40989816›Full record

ArticleRSC advances2025

Slow-release pesticide microparticles from polylactic acid and emamectin benzoate: preparation and characteristics.

Do Van Cong, Nguyen Vu Giang, Tran Huu Trung, Le Dang Quang, Nguyen Thi Thu Trang, Do Quang Tham, Tran Thi Mai, Nguyen Thi Huong

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Do Van CongInstitute of Materials Science, Vietnam Academy of Science and Technology Hanoi Vietnam dvcong@ism.vast.vn dovancongktnd@gmail.com.ORCID https://orcid.org/0000-0002-0024-1424
Nguyen Vu GiangInstitute of Materials Science, Vietnam Academy of Science and Technology Hanoi Vietnam dvcong@ism.vast.vn dovancongktnd@gmail.com.
Tran Huu TrungInstitute of Materials Science, Vietnam Academy of Science and Technology Hanoi Vietnam dvcong@ism.vast.vn dovancongktnd@gmail.com.
Le Dang QuangInstitute of Materials Science, Vietnam Academy of Science and Technology Hanoi Vietnam dvcong@ism.vast.vn dovancongktnd@gmail.com.
Nguyen Thi Thu TrangInstitute of Materials Science, Vietnam Academy of Science and Technology Hanoi Vietnam dvcong@ism.vast.vn dovancongktnd@gmail.com.
Do Quang ThamInstitute of Materials Science, Vietnam Academy of Science and Technology Hanoi Vietnam dvcong@ism.vast.vn dovancongktnd@gmail.com.
Tran Thi MaiInstitute of Materials Science, Vietnam Academy of Science and Technology Hanoi Vietnam dvcong@ism.vast.vn dovancongktnd@gmail.com.
Nguyen Thi HuongFaculty of Chemical Technology, Hanoi University of Industry Hanoi Vietnam.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emamectin benzoate (EMB) is a potent biological pesticide with broad-spectrum activity against various insects and fungi; however, its practical application is limited due to rapid degradation under UV irradiation, sunlight, and elevated temperatures. In this study, EMB was successfully encapsulated into polylactic acid (PLA) microparticles to enhance its stability, prolong its activity, and improve utilization efficiency. The effects of initial EMB content, PLA solution concentration, and particularly surfactant composition on the microparticle characteristics were systematically investigated. The optimized conditions yielded uniform microparticles with an average diameter of 3.24 μm, a loading content (LC) of 28.74%, and an encapsulation efficiency (EE) of 86.23%. The encapsulation markedly improved both UV and thermal stability of EMB, while

Identifiers

PMID40989816
PMCPMC12452081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.